US Patent 8163736 Cytotoxic agents comprising new tomaymycin derivatives

Is a

Patent

Patent attributes

Current Assignee

Sanofi

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

81637360

Patent Inventor Names

Herve Bouchard0

Ravi V. J. Chari0

Robert Zhao0

Wei Li0

Yonghong Deng0

Laurence Gauzy0

Alain Commercon0

Date of Patent

April 24, 2012

Patent Application Number

121741950

Date Filed

July 16, 2008

Patent Citations Received

‌

US Patent 12121590 Pyrrolobenzodiazepines and conjugates thereof

‌

US Patent 11707532 Compositions and methods of treating muscle dystrophy

‌

US Patent 11771775 Pyrrolobenzodiazepine-antibody conjugates

‌

US Patent 11779650 Pyrrolobenzodiazepine-antibody conjugates

‌

US Patent 11834510 Anti-transferrin receptor antibodies and uses thereof

‌

US Patent 11912779 Compositions and methods of treating facioscapulohumeral muscular dystrophy

‌

US Patent 11938192 Dosage regimes for the administration of an anti-CD19 ADC

‌

US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy

...

Patent Primary Examiner

‌

Bruck Kifle

Patent abstract

The present invention is related to new tomaymycin derivatives, their process of preparation and their therapeutic uses.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 8163736 Cytotoxic agents comprising new tomaymycin derivatives

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 8163736 Cytotoxic agents comprising new tomaymycin derivatives